HB Fuller (NYSE:FUL) Lowered to “Hold” at Zacks Investment Research

HB Fuller (NYSE:FUL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Monday, Zacks.com reports.

According to Zacks, “H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. H.B. Fuller’s commitment to innovation brings together people, products and processes that answer and solve some of the world’s biggest challenges. H.B. Fuller adhesives products used in manufacturing common consumer and industrial goods, including food and beverage containers, disposable diapers, windows, doors, flooring, appliances, sportswear, footwear, multi-wall bags, water filtration products, insulation, textiles, automotives, solar energy systems and electronics. H.B. Fuller also provides customers with technical support and unique solutions designed to address their specific needs. H.B. Fuller has established a variety of product offerings for residential construction markets, such as tile-setting adhesives, grout, sealants and related products. “

Other equities research analysts have also recently issued reports about the company. G.Research restated a “buy” rating on shares of HB Fuller in a research note on Tuesday, October 8th. Seaport Global Securities restated a “buy” rating on shares of HB Fuller in a research note on Tuesday, January 21st. Citigroup upgraded HB Fuller from a “sell” rating to a “neutral” rating and upped their target price for the stock from $46.00 to $50.00 in a research note on Friday, January 24th. Deutsche Bank upped their target price on HB Fuller from $50.00 to $52.00 and gave the stock a “hold” rating in a research note on Friday, January 24th. Finally, ValuEngine upgraded HB Fuller from a “sell” rating to a “hold” rating in a research note on Tuesday, December 24th. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $52.60.

Shares of FUL stock opened at $48.56 on Monday. The company has a current ratio of 2.36, a quick ratio of 1.55 and a debt-to-equity ratio of 1.77. The stock has a market cap of $2.46 billion, a P/E ratio of 19.27, a price-to-earnings-growth ratio of 1.44 and a beta of 1.57. The stock has a 50 day simple moving average of $50.17 and a 200 day simple moving average of $47.91. HB Fuller has a 1 year low of $39.22 and a 1 year high of $52.40.

HB Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, January 22nd. The specialty chemicals company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $739.10 million during the quarter, compared to the consensus estimate of $745.62 million. HB Fuller had a net margin of 4.52% and a return on equity of 13.12%. The company’s quarterly revenue was down 3.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 earnings per share. Analysts forecast that HB Fuller will post 3.25 EPS for the current year.

In other news, EVP Zhiwei Cai sold 55,688 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $51.80, for a total transaction of $2,884,638.40. Following the completion of the transaction, the executive vice president now directly owns 41,104 shares in the company, valued at $2,129,187.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sant R. William Van sold 10,000 shares of the company’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $51.67, for a total transaction of $516,700.00. Following the transaction, the director now owns 7,665 shares of the company’s stock, valued at $396,050.55. The disclosure for this sale can be found here. Insiders have sold 74,010 shares of company stock valued at $3,832,252 over the last 90 days. Corporate insiders own 3.46% of the company’s stock.

Several large investors have recently made changes to their positions in the company. BlackRock Inc. increased its holdings in shares of HB Fuller by 0.8% during the second quarter. BlackRock Inc. now owns 7,608,478 shares of the specialty chemicals company’s stock worth $353,034,000 after buying an additional 57,608 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of HB Fuller by 0.7% during the second quarter. Vanguard Group Inc. now owns 5,800,692 shares of the specialty chemicals company’s stock worth $269,153,000 after buying an additional 38,804 shares in the last quarter. State Street Corp increased its holdings in shares of HB Fuller by 2.0% during the third quarter. State Street Corp now owns 4,302,290 shares of the specialty chemicals company’s stock worth $200,315,000 after buying an additional 83,223 shares in the last quarter. Macquarie Group Ltd. increased its holdings in shares of HB Fuller by 0.6% during the second quarter. Macquarie Group Ltd. now owns 1,377,842 shares of the specialty chemicals company’s stock worth $63,932,000 after buying an additional 8,555 shares in the last quarter. Finally, Morgan Stanley increased its holdings in shares of HB Fuller by 283.1% during the second quarter. Morgan Stanley now owns 350,590 shares of the specialty chemicals company’s stock worth $16,268,000 after buying an additional 259,065 shares in the last quarter. Institutional investors own 98.34% of the company’s stock.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Further Reading: Guidelines for Successful Channel Trading

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.